| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 03/08/2007 | CA2620846A1 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 03/08/2007 | CA2620222A1 Organic compounds |
| 03/07/2007 | EP1760080A1 Design and synthesis of thiophene derived NLO materials for electro-optic applications |
| 03/07/2007 | EP1758655A2 Tetrahydropyridothiophenes for treating hyperproliferative disorders |
| 03/07/2007 | EP1518859B1 Process for the purification of thiophenes |
| 03/07/2007 | EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 03/07/2007 | EP1440066B1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 03/07/2007 | EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 03/07/2007 | EP1381370B1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists |
| 03/07/2007 | EP1349888B1 Polymeric crosslinkable compositions containing spiroorthocarbonates |
| 03/07/2007 | CN1926129A Novel insecticides |
| 03/07/2007 | CN1926083A Manufacturing method of optical activity alcohol |
| 03/07/2007 | CN1923834A Intermediate of olanzapine, preparation and application thereof |
| 03/07/2007 | CN1923818A Irreversible inhibitors of tyrosine kinases |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/06/2007 | US7186847 Process for the direct preparation of pyrrolo[3,4-c]pyrroles |
| 03/06/2007 | US7186832 anticancer agents; antidiabetic agents; autoimmune disease; restenosis; antiarthritic agents; skin disorders; cardiovascular disorders; antiinflammatory agents |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186722 active against sensitive and resistant species and against all development stages |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/01/2007 | WO2007024593A1 Fused tricyclic mglur1 antagonists as therapeutic agents |
| 03/01/2007 | WO2007023382A2 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 03/01/2007 | WO2007003961A3 Gpcr agonists |
| 03/01/2007 | WO2006014325A3 C-met modulators and method of use |
| 03/01/2007 | WO2006002105A8 Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 03/01/2007 | US20070049634 Microcrystals and pharmaceutical formulations comprising the same |
| 03/01/2007 | US20070049580 Anxiolytic agents with reduced sedative and ataxic effects |
| 03/01/2007 | CA2620052A1 Indenoisoquinolinone analogs and methods of use thereof |
| 03/01/2007 | CA2619362A1 Fused tricyclic mglur1 antagonists as therapeutic agents |
| 02/28/2007 | EP1757605A1 Cyclic amine compound |
| 02/28/2007 | EP1756118A1 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 02/28/2007 | EP1756117A2 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AS PROTEIN KINASE INHIBITORS |
| 02/28/2007 | EP1756116A1 Polymorphic forms of methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate hydrobromide, clopidrogel hydrobromide |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1755610A2 Thienopyrimidines and thiazolopyrimidines for use in medicine |
| 02/28/2007 | EP1425286B1 Substituted 7-aza-[2.2.1]bicycloheptanes for the treatment of diseases |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | CN1922189A Spirocyclic cyclohexane derivatives with affinity for the ORL1-receptor |
| 02/28/2007 | CN1922188A Pharmacologically acceptable salts of clopidogrel |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1921170A Organic semiconductor material, organic semiconductor element and field effect transistor using the same |
| 02/28/2007 | CN1301997C Benzosulfones with calcium antagonist activity |
| 02/27/2007 | US7183419 Reacting a 2,5-di(alkoxycarbonyl)-3,4-dihydroxythiophene or the alkali metal salt thereof with a ditosylate and cleaving the ester and decarboxylating the intermediate thus formed; used as monomers for pi-conjugated polymers |
| 02/27/2007 | US7183418 Use as semiconductors or charge transport materials in optical, electrooptical or electronic devices such as liquid crystal displays, organic field effect transistors, integrated circuit devices such as radio frequency identification tags (RFID) |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183282 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/27/2007 | US7183067 Versatile linker compound, ligand, and producing method thereof |
| 02/22/2007 | WO2007022280A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | WO2007022268A2 Compounds and compositions as protein kinase inhibitors |
| 02/22/2007 | WO2007022068A1 Olanzapine analogs and methods of use thereof |
| 02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | WO2007020080A1 A process for making olanzapine form i |
| 02/22/2007 | WO2007019914A1 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 02/22/2007 | WO2007019884A1 Novel 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides |
| 02/22/2007 | WO2007019674A1 Viral polymerase inhibitors |
| 02/22/2007 | WO2006134163A8 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 02/22/2007 | US20070043080 Substituted anilinic piperidines as MCH selective antagonists |
| 02/22/2007 | US20070043069 3-Amino-3,4-dihydro-1,5-naphthyridin-2(1H)-one and its dihydrochloride; intermediates for producing naphthyridinylaminocarbonyl-substituted pyrrolothiopyrans and imidazolothiopyrans |
| 02/22/2007 | US20070043044 such as 2-Amino-4-phenyl-thieno[2,3-d]pyrimidine-6-carboxylic acid ethylamide; veterinary medicine; anticancer agents |
| 02/22/2007 | US20070043038 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 02/22/2007 | CA2619505A1 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 02/22/2007 | CA2619462A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | CA2619459A1 Novel 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides |
| 02/22/2007 | CA2619049A1 Compounds and compositions as protein kinase inhibitors |
| 02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | CA2617107A1 Olanzapine analogs and methods of use thereof |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1754701A1 Sulfonyloxy derivatives |
| 02/21/2007 | EP1754483A1 Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them |
| 02/21/2007 | EP1753769A2 Method of making dorzolamide hydrochloride |
| 02/21/2007 | EP1753768A1 POLYMERISABLE THIENO¬3,2-b|THIOPHENES |
| 02/21/2007 | EP1753734A1 Nitric oxide donors and uses thereof |
| 02/21/2007 | EP1753512A2 Tetrahydropyridothiophenes |
| 02/21/2007 | EP1753428A2 Kinase inhibitors as therapeutic agents |
| 02/21/2007 | EP1753419A1 Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179830 Such as 2-(4-methyl-3-thienylamino)-1H-thieno[3,4-d]imidazole for treatment of repiratory disorders, sleep apnea |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | CA2263561C Thienopyrimidines |
| 02/15/2007 | WO2007019295A1 Methods of preparing quinolone analogs |
| 02/15/2007 | WO2007018225A1 Method of staining substance having phosphate group |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007017886A1 Novel process for preparation of clopidogrel bisulphate polymorphic form i |
| 02/15/2007 | WO2007017540A1 Novel biotin reagent, methods of preparing and labelling same and uses thereof |
| 02/15/2007 | WO2006067614B1 Heteroaromatic derivatives useful as anticancer agents |
| 02/15/2007 | US20070037852 Migrastatin analogs and uses thereof |
| 02/15/2007 | US20070037842 Polymorphs and amorphous form of (s)-(+)-clopidogrel bisulfate |
| 02/15/2007 | US20070037805 Fused heteroaryl derivatives |
| 02/15/2007 | US20070037798 Thiolactones |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/14/2007 | EP1752458A2 Low molecular weight conjugated nitrogen compounds and devices obtainable using the same |